Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 197 clinical trials
None

  • None views
None

  • None views
None

  • None views
None

  • None views
None

  • None views
None

  • None views
None

  • None views
None

  • None views
Efficacy and Safety of Cabozantinib in Patients With Hepatocellular Carcinoma

This is an open-label, single-center, Phase II trial designed to estimate in terms of PFS the efficacy of cabozantinib, given as second- or third- line treatment in HCC patients that progress on or are intolerant to immune checkpoint inhibitors, including anti-PD-1 and anti-PD-L1 antibodies.

renal function test
antiviral therapy
TACE
carcinoma
antiviral drugs
  • 0 views
  • 19 Feb, 2024
  • 1 location
Combination of PD-1 and VEGFR-2 Blockade for Advanced Hepatocellular Carcinoma

The aie of this clinical study is the safety and efficacy of combination therapy for HCC patients.

measurable disease
granulocyte colony stimulating factor
HIV Infection
carcinoma
systemic chemotherapy
  • 0 views
  • 19 Feb, 2024
  • 1 location